Navigation Links
MedCath Announces Venture With Two New Jersey Hospitals
Date:2/19/2008

CHARLOTTE, N.C., Feb. 19 /PRNewswire-FirstCall/ -- MedCath Corporation (Nasdaq: MDTH) announced today that MedCath Partners, LLC has entered into a new strategic relationship with Solaris Health System of Edison, N.J.

MedCath Partners, LLC, will participate in a new venture to manage the catheterization laboratories of Solaris's two acute care hospitals, JFK Medical Center and Muhlenberg Regional Medical Center. Solaris, local cardiologists, and MedCath will own equal shares of the management company.

"Our partnership with MedCath will reinforce our commitment to providing quality and compassionate healthcare services to our diverse communities," said John P. McGee, President and Chief Executive of Solaris. "We value MedCath's experience in providing excellent cardiovascular services and maintaining strong relationships with the cardiologists. We are excited about using this venture as a way to continue to improve the scope and quality of cardiovascular services to the patients in our community."

Edison-based JFK Medical Center consists of a 399 bed teaching hospital and the adjacent 94 bed JFK Johnson Rehabilitation Institute. Muhlenberg Regional Medical Center is a 396-bed acute care facility in Plainfield, N.J., that provides inpatient and outpatient services in all major medical specialties. Solaris was created in 1997 when the two hospitals consolidated into one organization. The Solaris network also includes long-term care centers, assisted living communities and schools of nursing, medical imaging and therapeutic sciences.

"This venture with Solaris - MedCath Partners' third agreement announced since last summer - is a key element in our five-point strategic growth plan for MedCath," said Ed French, MedCath's President and Chief Executive Officer. "We are excited about the opportunity to work with such an excellent organization and high-quality physicians to expand this cardiac catheterization program in Central New Jersey."

MedCath will make a capital investment of approximately $1.0 million in the venture and the other members will make pro rata capital contributions as well. MedCath anticipates that this venture will add $0.02 earnings per diluted share annually.

MedCath Partners, LLC's primary focus is assisting healthcare organizations form joint ventures to manage hospital-based cardiac catheterization laboratories.

MedCath Corporation, headquartered in Charlotte, N.C., is a healthcare provider focused on high acuity services with the diagnosis and treatment of cardiovascular disease being a primary service offering. MedCath owns interests in and operates ten hospitals with a total of 663 licensed beds, located in Arizona, Arkansas, California, Louisiana, New Mexico, Ohio, South Dakota, and Texas. In addition, MedCath and its subsidiary MedCath Partners provide services in diagnostic and therapeutic facilities in various states.

Parts of this announcement contain forward-looking statements that involve risks and uncertainties. Although management believes that these forward- looking statements are based on reasonable assumptions, these assumptions are inherently subject to significant economic, regulatory and competitive uncertainties and contingencies that are difficult or impossible to predict accurately and are beyond our control. Actual results could differ materially from those projected in these forward-looking statements. We do not assume any obligation to update these statements in a news release or otherwise should material facts or circumstances change in ways that would affect their accuracy.

These various risks and uncertainties are described in detail in "Risk Factors" in MedCath's Form 10-K filed with the Securities and Exchange Commission on December 14, 2007. A copy of this registration statement, including exhibits, is available on the internet site of the Securities and Exchange Commission at http://www.sec.gov.


'/>"/>
SOURCE MedCath Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. MedCath Corporation Reports Fourth Quarter Earnings and Outlook for Fiscal 2008
2. MedCath Corporation to Present at the BMO Capital Markets 2007 Focus on Healthcare Conference
3. MedCath Corporation to Present at the 26th Annual JPMorgan Healthcare Conference
4. MedCath Corporation to Hold Conference Call on First Quarter Results
5. MedCath Corporation Reports First Quarter Earnings
6. MedCath Plans 60-bed Expansion at TexSAn Heart Hospital
7. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
8. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
9. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
10. HEI, Inc. Announces Sale of RFID Division Assets
11. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/3/2016)... ... 03, 2016 , ... With the opioid epidemic now at the forefront, attention ... use. Alcohol and its misuse causes long-term consequences for all aspects of society, ... in those 65 years and older. In addition, there is the long term ...
(Date:5/3/2016)... ... May 03, 2016 , ... ... DNA or RNA from a random library of sequences depending on their attraction ... or diagnostic agents. SELEX selection is commonly performed using filters, panning, or affinity ...
(Date:5/3/2016)... ... 2016 , ... Sandbox, one of the nation’s leading independent ... newly created position of executive vice president, chief creative officer.     , In his ... and LA offices. He reports to Nancy Finigan, president of those offices. , ...
(Date:5/3/2016)... ... , ... Elizabeth Murray has always loved walking one to two miles a ... shoulder and one on her arm. But she got to the point where she ... prolapse. , The valves of the heart wouldn’t close properly resulting in mitral regurgitation, ...
(Date:5/3/2016)... ... 03, 2016 , ... Excessive panting in the car or cowering when new ... often think anxiety only manifests itself as trembling or ‘tail between the legs,’ but ... that be done about it,” says Dr. Jim Lowe, technical services veterinarian for Tomlyn ...
Breaking Medicine News(10 mins):
(Date:5/3/2016)... acquired a major investment from Sino-German High-Tech Fund to further expand product development, strengthen its disease modeling capabilities and ... ... ... ... ...
(Date:5/3/2016)...   BIOTRONIK will be exhibiting and initiating ... implant at the Heart Rhythm Society,s 37 th ... Francisco . "Physicians and hospitals ... patient care and satisfaction possible. Part of that process ... tomorrow," said Marlou Janssen , President, BIOTRONIK, Inc. ...
(Date:5/3/2016)... , May 3, 2016 ... INTP), a clinical-stage biopharmaceutical company, today announced the appointment ... and Regulatory Affairs. "Ms. Strauss-Levy has 15 ... and has established an outstanding track record, having supported ... and regulatory approval processes in the United ...
Breaking Medicine Technology: